Article Listing - Novo Nordisk's Ryzodeg passes regulatory hurdle in Japan; diabetes burden review

GLOBAL MARKETS AND FACTORS FOR SUCCESS

6 April 1992

As the geographical borders between pharmaceutical markets begin to disappear, so do the differences among the critical success factors for...

HERBAL MEDICINES IN ASIA 1992-96

6 April 1992

The international management consulting company McAlpine Thorpe and Warrier Ltd, which specializes in the field of herbal medicines, has announced...

STOCK MARKET COMMENTARY: EUROPE

6 April 1992

EUROPE: saw most bourses weak at the start of the reporting period, but strengthen as time went on. By the...

REDUCING ASTHMA COSTS IN THE USA

6 April 1992

A study looking at the economic aspect of asthma in the USA has found that there are a number of...

FURTHER FALLS FOR DEPRENYL?

6 April 1992

Shares of the Canadian biopharmaceutical company Deprenyl Re-search have recently lost value and could well fall further, according to local...

NEW PRES AT PROCORDIA

6 April 1992

Jan Ekberg has been named as president and chief executive at Procordia, in succession to Soren Gyll who has become...

ARIAD PHARMACEUTICALS STOCK SALE

6 April 1992

The biotechnology concern Ariad Pharmaceuticals of the USA is reported to have raised $46 million in a private stock sale,...

CHIROS ACQUIRES ENZYMATIX' CHIRAL DIV

6 April 1992

A new UK company, Chiros Ltd, was formed last month to purchase the assets and business of the Chiral division...

US PHARMACY COMPOUNDING GUIDE

6 April 1992

The US Food and Drug Administration has, for the first time, issued a pharmacist compounding compliance guide, due to the...

GERMAN POLICY UNDER FIRE

6 April 1992

German Health Minister Gerda Hasselfeldt has accused the leading German doctors' organization, the Hartmannbund, of political agitation, after it held...

Showing 94511-94520 of 95333 articles